The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 36 X posts from 27 X users, with an upper bound of 144,041 followers.

RT @sitcancer: #JITC Research: The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune act…

RT @sitcancer: #JITC Research: The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune act…

RT @sitcancer: #JITC Research: The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune act…

RT @sitcancer: #JITC Research: The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune act…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 32 additional X posts.